Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

20,711 total articles

Alliance Entertainment to Host Fiscal Year 2026 Results Conference Call on September 10 at 4:30 p.m. Eastern Time

Alliance Entertainment to Host Fiscal Year 2026 Results Conference Call on September 10 at 4:30 p.m. Eastern Time

Alliance Entertainment Holding Corporation will host a conference call on September 10, 2026, to discuss its fiscal year 2026 financial results, providing investors and analysts with an update on the company’s performance. The company operates as a major distributor and fulfillment partner in the entertainment and pop culture collectibles industry.

E-Power Awarded RMB 343 Million (Approximately US$51.04 Million) Turnkey Contract to Deliver Artificial Graphite and Silicon-Carbon Anode Production Lines

E-Power Awarded RMB 343 Million (Approximately US$51.04 Million) Turnkey Contract to Deliver Artificial Graphite and Silicon-Carbon Anode Production Lines

E-Power Inc. announced a significant contract worth approximately $51.1 million awarded to its subsidiary Shandong Sunrise to design, supply, and commission two anode production lines in China, expanding the company's role from materials producer to full-solution provider in battery materials technology. This contract represents E-Power's largest t…

Change Agents Announces 1-for-20 Reverse Stock Split

Change Agents Announces 1-for-20 Reverse Stock Split

Change Agents Corporation, a Nasdaq-listed artificial intelligence software company, announced a 1-for-20 reverse stock split effective August 28, 2026, aiming to increase its per share market price to comply with Nasdaq's minimum $1 bid price requirement. This move will reduce the number of outstanding shares from approximately 21.1 million to 1.0…

Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit

Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit

Propanc Biopharma announced promising new preclinical data for its lead candidate PRP in treating pancreatic ductal adenocarcinoma. PRP demonstrated over 90% tumor growth inhibition, reduced metastasis, and a more than 2.5-fold median survival extension in animal models. The therapy operates via a unique, non-cytotoxic mechanism targeting tumor mic…

Biomerica Announces $2.23 Million Financing

Biomerica Announces $2.23 Million Financing

Biomerica, Inc., a Nasdaq-listed biomedical diagnostics company, announced a $2.23 million private placement priced at $1.60 per share with participation from B. Riley Principal Capital, company executives, and board members. The proceeds will bolster the company's financial position, support ongoing operations, and facilitate evaluation of strateg…

Debt Settlement Enrollment Linked to Greater Credit Score Declines Than Bankruptcy, New TransUnion Research Finds

Debt Settlement Enrollment Linked to Greater Credit Score Declines Than Bankruptcy, New TransUnion Research Finds

TransUnion's new analysis finds consumers enrolling in third-party debt settlement programs experience greater credit score declines than bankruptcy filers. Nearly half of enrollees were current on payments prior to enrollment. Combining bankruptcy-related signals with credit trend data improves identification of consumers likely to enter debt sett…

Callan Power to Acquire Williston Basin Non-Operated Oil and Gas Assets with $48 Million Proved PV-10 and $83 Million 3P PV-10 from The Pfanenstiel Company, Significantly Expanding Energy Assets

Callan Power to Acquire Williston Basin Non-Operated Oil and Gas Assets with $48 Million Proved PV-10 and $83 Million 3P PV-10 from The Pfanenstiel Company, Significantly Expanding Energy Assets

Callan JMB Inc., through its subsidiary Callan Power LLC, announced the acquisition of non-operated working interest in 377 producing oil and gas wells and additional 27 wells in process across the Williston Basin for $12.5 million in cash. The assets have an independently estimated proved PV-10 value of approximately $48 million and total 3P PV-10…

ZenaTech Named 2026 “Drone Technology of the Year” Winner by AgTech Breakthrough Awards for Its ZenaDrone Precision Agriculture Solutions

ZenaTech Named 2026 “Drone Technology of the Year” Winner by AgTech Breakthrough Awards for Its ZenaDrone Precision Agriculture Solutions

ZenaTech, Inc. announced that its subsidiary ZenaDrone has won the 'Drone Technology of the Year' award by the AgTech Breakthrough Awards for its AI-powered drones advancing precision agriculture. Their drone solutions, currently in testing and pilot stages, assist farmers in early crop stress detection, precise irrigation, fertilizer application, …

AZIO AI Increases Estimated Sales Pipeline to Approximately $307 Million for Up to 512 NVIDIA HGX B300 Systems in Expanded Power Champion Agreement

AZIO AI Increases Estimated Sales Pipeline to Approximately $307 Million for Up to 512 NVIDIA HGX B300 Systems in Expanded Power Champion Agreement

AZIO AI Holdings, Inc. has expanded its agreement with Power Champion Investment Limited to potentially provide up to 512 NVIDIA HGX B300 GPU systems, increasing the estimated sales pipeline value to approximately $307 million. This expansion follows the company's announcement of Atlas One, a South Texas AI compute infrastructure campus engineered …

BranchOut Secures Approximately $750,000 in Initial Orders for New Front-of-Club Multipack Product Line and Dried Cheesecake Bites with Nation's Largest Warehouse Club Retailer

BranchOut Secures Approximately $750,000 in Initial Orders for New Front-of-Club Multipack Product Line and Dried Cheesecake Bites with Nation's Largest Warehouse Club Retailer

BranchOut Food Inc. announced initial commercial orders totaling approximately $750,000 for its new front-of-club Crunchy Fruit Chip Multipack Product Line and shelf-stable Dried Cheesecake Bites with the nation’s largest warehouse club retailer. The multipack line is set for launch in Mexico, marking the company's first international warehouse clu…

SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform

SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform

SL Science Holding Limited filed a new Drug Master File with the FDA covering exosomes derived from Gamma Delta T cells. This expands their regulatory documentation beyond just the GDT cells to include the cell-free exosomes, potentially accelerating future development programs. The exosome format may overcome delivery challenges in oncology, notab…

PodcastOne (Nasdaq: PODC) Acquires Exclusive Sales and Distribution Rights to Dropping Names…and Other Things with Brent & Jonny in Multi-Year Deal

PodcastOne (Nasdaq: PODC) Acquires Exclusive Sales and Distribution Rights to Dropping Names…and Other Things with Brent & Jonny in Multi-Year Deal

PodcastOne has acquired exclusive sales and distribution rights to the entertainment podcast ‘Dropping Names… and Other Things with Brent & Jonny,’ hosted by actors Brent Spiner and Jonathan Frakes. This deal expands PodcastOne's portfolio with its 12th new podcast addition this year, broadening its reach in the entertainment podcast sector and enh…

red violet to Present at Citi’s 2026 Global TMT Conference

red violet to Present at Citi’s 2026 Global TMT Conference

Red Violet, Inc., a leading identity intelligence and analytics company, announced its participation at Citi's 2026 Global TMT Conference. The company’s CEO and CFO will present and host investor meetings, highlighting its proprietary identity intelligence technologies and AI-powered platform CORE™ used for identity verification, risk mitigation, a…

Artelo Biosciences Announces Reverse Stock Split

Artelo Biosciences Announces Reverse Stock Split

Artelo Biosciences, a clinical-stage pharmaceutical company, declared a 1-for-9 reverse stock split of its common stock effective August 31, 2026. This corporate action aims to increase the stock price per share to enhance liquidity and marketability without changing shareholder ownership percentages. All outstanding warrants and derivatives will b…

CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)

CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)

CytomX Therapeutics announced that the FDA has granted Fast Track Designation to its investigational drug Varsetatug masetecan (Varseta-M) for treating relapsed/refractory metastatic colorectal cancer (R/R mCRC). This designation follows encouraging Phase 1 data and is intended to expedite development and review. CytomX plans to initiate a registra…

Enviri Corporation to Participate in Upcoming Investor Conferences

Enviri Corporation to Participate in Upcoming Investor Conferences

Enviri Corporation (NYSE: NVRI), a leading environmental and operational solutions provider in the metal and rail industries, announced its management will participate in the Jefferies Global Industrials Conference and the Lake Street Best Ideas Growth Conference in New York on September 9 and 10, 2026 respectively. The participation underscores En…

Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes

Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes

Milestone Pharmaceuticals announced data from a longitudinal study showing that paroxysmal supraventricular tachycardia (PSVT) significantly affects patients' daily lives and quality of life even between acute episodes. The study highlights lifestyle changes, activity avoidance, persistent anxiety, and medication side effects as contributors to the…